RAD51 and neoplasm: The herein presented RAD51-based functional HR (fHR) test on immunostained FFPE sections quantifies real-time function of HR repair in the tumor, does not require high tumor cell content and works on both treatment-naïve and NACT-treated HGSC specimens.